The 3 Best Stocks to Invest $3,000 in Right Now

Following recent AI-driven market volatility, the article recommends three stocks as solid investment opportunities: Shopify, which shows strong fundamentals despite a recent sell-off; Dell Technologies, positioned to benefit from practical AI solutions for enterprise customers; and Snap, a riskier pick leveraging AI to improve operational efficiency and user engagement.

11/12/2026, 5:15 AM • The Motley Fool

Magnite vs. Snap: Which Ad Tech Stock Is a Better Buy Going Into 2027?

The article compares two ad tech stocks: Magnite, a leading independent sell-side advertising platform focused on connected TV, and Snap, a social media platform with nearly 1 billion users. While Snap appears cheaper on valuation metrics, the author recommends Magnite for 2027 due to stronger financial health, profitability, and growth momentum in the CTV market, whereas Snap faces user retention challenges and higher debt levels.

11/11/2026, 8:41 PM • The Motley Fool

These 5 Internet Platform Stocks Run on Advertising Dollars

Five major internet platforms—Alphabet, Meta, Pinterest, Snap, and Reddit—all rely heavily on advertising revenue, but their dependence varies significantly. Ad growth slowed across all five companies from Q2 to Q3. Alphabet is the most diversified with Google Cloud offsetting ad slowdown, while Meta still shows strong 26% ad revenue growth. Pinterest, Snap, and Reddit face more concerning trends with slowing growth and audience challenges.

11/10/2026, 1:47 AM • The Motley Fool

Pinterest vs. Snap: Which Media Stock Is a Better Buy Going into 2027?

The article compares Pinterest and Snap as investment options for 2027. While Snap appears cheaper on valuation metrics (Forward P/E of 7.9x vs Pinterest's 9.7x), the author recommends Pinterest due to its superior profitability, user growth momentum, and stronger financial health. Pinterest achieved $4.2B in revenue with a 9.9% net margin and 661M monthly active users, while Snap reported a net loss of $460.5M despite $5.9B in revenue, with declining North American users.

11/08/2026, 2:12 PM • The Motley Fool

Stock Market Today, Oct. 27: Meta Raises Largest-Ever Equity Offering to Nearly $98 Billion to Fund AI Infrastructure Bet

Meta Platforms raised $97.5 billion in its largest-ever equity offering to fund massive AI infrastructure investments projected at $135-145 billion in 2026. The offering was oversubscribed fivefold, and Nvidia and AMD pledged $4 billion in investments. Despite strong Q3 results with 26% revenue growth, Meta's stock fell 1.65% as investors weighed heavy capital expenditures against future returns.

10/27/2026, 5:16 PM • The Motley Fool

Reddit vs. Snap: Which Social Media Stock Is a Better Buy in 2026?

Reddit and Snap are compared as social media investment options for 2026. Reddit demonstrates superior financial performance with 69.4% revenue growth, 24.1% net margin, and profitability, while Snap shows slower 10.6% growth and remains unprofitable with a -7.8% net margin. The analyst recommends Reddit over Snap, citing Reddit's stronger user engagement, consistent profitability, and better growth trajectory despite Snap's lower valuation multiples.

10/27/2026, 2:08 AM • The Motley Fool

Hims & Hers Health (HIMS) Alert: Securities Class Action Pending, Investors with Losses Encouraged to Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline

Hims & Hers Health faces a securities class action lawsuit following an FTC federal complaint alleging deceptive health data sharing with third-party advertising platforms and ROSCA violations related to subscription billing practices. The allegations caused HIMS stock to plunge $4.32 (-14.7%) on July 29, 2026, erasing over $970 million in market capitalization. Investors with losses are encouraged to contact Hagens Berman before the November 2, 2026 lead plaintiff deadline.

10/25/2026, 2:21 PM • GlobeNewswire

AppLovin vs. Snap: Which Technology Stock Is a Better Buy in 2026?

AppLovin and Snap are compared as advertising-focused technology stocks for 2026. AppLovin demonstrates exceptional growth with 70% revenue increase, 60.8% net margins, and $3.9B free cash flow, while Snap serves 971M users but remains unprofitable with -7.8% net margins despite improving losses. The article recommends AppLovin due to its superior profitability and growth trajectory versus Snap's ongoing path to consistent profitability.

10/21/2026, 8:13 AM • The Motley Fool

INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS

Robbins Geller announces a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' health information with third-party advertising platforms and charging for prescriptions immediately after intake forms despite claiming personalized consultations. The FTC filed a lawsuit on July 29, 2026, leading to a 15% decline in Hims & Hers stock. Investors with substantial losses can seek lead plaintiff status before November 2, 2026.

10/15/2026, 7:00 AM • GlobeNewswire

Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action

Robbins LLP is reminding investors of a pending class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' sensitive health information with advertising platforms while claiming privacy protection, and engaging in deceptive billing practices. The FTC filed a lawsuit on July 29, 2026, which caused HIMS stock to decline 14.73%. Investors who purchased securities between August 4, 2025 and July 29, 2026 may be eligible to participate, with a lead plaintiff deadline of November 2, 2026.

10/14/2026, 7:53 PM • GlobeNewswire

Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower - HBSS

Hims & Hers Health (NYSE: HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company deceptively shared consumers' health data with third-party advertising platforms like Meta and Snap, and violated billing regulations by charging for prescriptions before medical consultations. The stock plunged 14.7% on July 29, 2026, erasing over $970 million in market value.

10/09/2026, 6:12 PM • GlobeNewswire

1 MONTH INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS

Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Hims & Hers Health, Inc. following FTC allegations that the telehealth provider shared consumers' sensitive health information with third-party advertising platforms including Meta and Snap, and engaged in deceptive billing practices. The lawsuit covers securities purchased between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026. Hims & Hers shares declined nearly 15% following the FTC announcement.

10/02/2026, 6:50 AM • GlobeNewswire

Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit—HBSS

Hims & Hers Health (HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company shared consumers' health data with third-party advertisers like Meta and Snap, charged for prescriptions before medical consultations, and violated ROSCA regulations. The stock dropped 14.7% on July 29, 2026, erasing over $970 million in market value. Investors with substantial losses are encouraged to participate in the class action.

09/30/2026, 10:59 AM • GlobeNewswire

Upcoming Blaze Wilde Podcast on Snapchat Exploring Pop Culture, Politics, and Life Between Arab and American Culture

cauZmik Inc is launching a new Snapchat podcast in partnership with Los Angeles-based model and creator Blaze Wilde in October 2026. The podcast will feature candid conversations about pop culture, politics, Arab identity, and Wilde's experiences living between the UAE and the United States, drawing from his modeling career and social media presence.

09/26/2026, 12:24 PM • GlobeNewswire

HIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages HIMS Investors with Losses to Contact the Firm

A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making materially false statements about its privacy practices. The FTC accused HIMS of sharing customers' medical information with third-party advertisers including Meta and Snap, and charging consumers for prescriptions without proper consultation. The stock declined 14.73% on the news, dropping $4.32 per share to $25.00 on July 29, 2026.

09/25/2026, 4:51 PM • GlobeNewswire